Skip to NavigationSkip to content

News

Israeli drugmaker Teva has announced that its calcitonin gene-related peptide (CGRP) inhibitor Ajovy (remanezumab-vfrm) has received FDA approval...
US pharma giant MSD will offer cutting edge cancer treatment Keytruda to Chinese patients at half the price at what it is sold for in the United...
Almirall has announced that the European Commission has approved its interleukin-23 (IL-23) inhibitor Ilumetri (tildrakizumab) for the treatment of...
The National Institute for health and Care Excellence (NICE) has rejected Novartis’ CAR-T therapy Kymriah for use in adults with relapsed or...
Novartis has announced it is to relocate its operations in Arnhem in the Netherlands to the capital city of Amsterdam, according to Dutch regional...
The Anglo-Swedish multinational AstraZeneca is moving towards becoming a major healthcare provider in China as part of an effort to expand the...
The US Food and Drug Administration is set to introduce a requirement that all healthcare providers be offered educational training in pain...
Cancer Research UK has announced a £14 million investment to build a new hub in London for cancer research and treatment to create “a global centre...
The number of people who are receiving the 12 routine childhood vaccinations has declined in proportion to the eligible population according to...
The US Senate have passed a bipartisan bill aimed at combatting the opioid crisis through new research, treatment and help for families suffering...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches